Regeneration: Hold your breath!
- Ruprecht-Karls-University Heidelberg, Germany
Regeneration, the process by which an animal restores lost cells or body parts, occurs throughout the animal kingdom, including vertebrates, planarians and cnidarians such as hydra (Tanaka & Reddien, 2011). However, the ability to regenerate varies between species, and within a species it can be different for different body parts. Salamanders, such as axolotls and newts, possess the most impressive regenerative capabilities among the vertebrates, and are capable of regenerating entire organs and limbs.
One salamander in particular, the red spotted newt, has the ability to do something remarkable – to regenerate brain cells and tissue in response to damage caused by chemicals (Parish et al., 2007; Berg et al., 2010). They are also able to cope with low levels of oxygen (hypoxia) in the water they live in. Since hypoxia and re-oxygenation can cause tissue damage, András Simon of the Karolinska Institute and colleagues – including Shahul Hameed as first author – decided to investigate the effects of these two processes on cell death and regeneration in the forebrain of the newt (Hameed et al., 2015).
Previous studies have shown that the death of cells after an injury leads to the activation of the immune system and an inflammatory response. Immune cells called microglia start to divide (proliferate) and migrate to the site of the injury, where they engulf and destroy the dead neurons (Wake et al., 2013). Hameed et al. found that the newts were able to survive in the hypoxic conditions for days. However, exposing the newts to hypoxia followed by re-oxygenation caused some neurons in the forebrain to die, and also led to an increase in the number of active microglia cells in the brain. They also found that cells called ependymoglia stem cells – which replace neurons as part of normal body maintenance and after injury (Parish et al., 2007; Berg et al., 2010) – replaced the neurons that died after hypoxia and re-oxygenation (Figure 1).
Figure 1
The reactive oxygen species (ROS) that are produced after damage to neurons are necessary for regeneration of the newt brain.
Exposure to hypoxia followed by re-oxygenation, or deliberate chemical damage (ablation), leads to the loss of neurons (orange) in red spotted newts, and also causes immune cells called microglia (grey) to proliferate. In ependymoglia stem cells (green), ROS are produced inside mitochondria and by NOX proteins at the cell membrane. Only NOX-derived ROS, which can be inhibited by the drug apocynin (bold red lines), are necessary for the proliferation of ependymoglia stem cells and the subsequent regeneration of lost neurons. Inhibiting the microglia with a drug called Dexamethasone (thin red lines) has no effect on the proliferation of the ependymoglia stem cells, which suggests that inflammation does not influence the regeneration of neurons. Bold black lines represent processes that are necessary for regeneration; the processes represented by thin black lines are not necessary for regeneration.
Periods of hypoxia followed by re-oxygenation are known to induce 'oxidative' stress in cells and tissues: this can lead to the production of reactive oxygen species (ROS) that often damage proteins and other molecules, and it can also destabilize the genome (Schieber & Chandel, 2014). However, it has recently become clear that ROS can also promote cell division (Le Belle et al., 2011) and can even be necessary for regeneration (Love et al., 2013). Hameed et al. found that the production of ROS increased in ependymoglia stem cells after hypoxia and re-oxygenation. The ROS were produced by the mitochondria in the cells, and by NADPH oxidase complex (NOX) proteins in the cell membrane. Experiments with drugs that inhibit the production of ROS showed that only the ROS that were produced by the NOX proteins are required for the ependymoglia stem cells to increase in number.
Recently it was shown that inflammation can promote regeneration of the zebrafish brain (Kyritsis et al., 2012) and axolotl limbs (Godwin et al., 2013). However, Hameed et al. found that the proliferation of ependymoglia stem cells in the newt brain does not depend on inflammation. Additionally, increases in ROS did not influence the activation of microglia. Therefore, unlike in many other systems, there is not a close relationship between hypoxia and inflammation in the newt brain.
Finally, Hameed et al. addressed the role of ROS in the regeneration of dopaminergic neurons in the midbrain under normal oxygen conditions. Chemical damage to these neurons led to increased production of ROS in the ependymoglia stem cells, and the experiments confirmed that this increased production was required for the neurons to regenerate. However, the high levels of ROS observed would normally kill neurons and other cells, which raises the question: how can ependymoglia stem cells cope with these levels of ROS and use them as a cue to start dividing?
Another question raised by these findings is whether ROS play a similar role in brain regeneration in other animals. Previous studies have shown that brain regeneration in zebrafish depends on inflammation. However, since zebrafish are also able to survive in environments that can become hypoxic, it is possible that they may also have another mechanism for brain regeneration that involves ROS. How different regenerative abilities are either lost or gained during evolution has been discussed for a long time, but is not well understood and is extremely difficult to study. It will be exciting to observe how the recent findings by Hameed et al. will stimulate and contribute to these studies.
References
-
Macrophages are required for adult salamander limb regenerationProceedings of the National Academy of Sciences 110:9415–9420.https://doi.org/10.1073/pnas.1300290110
-
ROS function in redox signaling and oxidative stressCurrent Biology 24:R453–R462.https://doi.org/10.1016/j.cub.2014.03.034
-
The cellular basis for animal regenerationDevelopmental Cell 21:172–185.https://doi.org/10.1016/j.devcel.2011.06.016
-
Microglia: actively surveying and shaping neuronal circuit structure and functionTrends in Neurosciences 36:209–217.https://doi.org/10.1016/j.tins.2012.11.007
Article and author information
Author details
Publication history
- Version of Record published: December 16, 2015 (version 1)
Copyright
© 2015, Lust et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,800
- views
-
- 131
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Regeneration: Hold your breath!
eLife 4:e12523.
https://doi.org/10.7554/eLife.12523
Further reading
-
- Cell Biology
- Neuroscience
Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.
-
- Cell Biology
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disorder characterized by progressive weakness of almost all skeletal muscles, whereas extraocular muscles (EOMs) are comparatively spared. While hindlimb and diaphragm muscles of end-stage SOD1G93A (G93A) mice (a familial ALS mouse model) exhibit severe denervation and depletion of Pax7+satellite cells (SCs), we found that the pool of SCs and the integrity of neuromuscular junctions (NMJs) are maintained in EOMs. In cell sorting profiles, SCs derived from hindlimb and diaphragm muscles of G93A mice exhibit denervation-related activation, whereas SCs from EOMs of G93A mice display spontaneous (non-denervation-related) activation, similar to SCs from wild-type mice. Specifically, cultured EOM SCs contain more abundant transcripts of axon guidance molecules, including Cxcl12, along with more sustainable renewability than the diaphragm and hindlimb counterparts under differentiation pressure. In neuromuscular co-culture assays, AAV-delivery of Cxcl12 to G93A-hindlimb SC-derived myotubes enhances motor neuron axon extension and innervation, recapitulating the innervation capacity of EOM SC-derived myotubes. G93A mice fed with sodium butyrate (NaBu) supplementation exhibited less NMJ loss in hindlimb and diaphragm muscles. Additionally, SCs derived from G93A hindlimb and diaphragm muscles displayed elevated expression of Cxcl12 and improved renewability following NaBu treatment in vitro. Thus, the NaBu-induced transcriptomic changes resembling the patterns of EOM SCs may contribute to the beneficial effects observed in G93A mice. More broadly, the distinct transcriptomic profile of EOM SCs may offer novel therapeutic targets to slow progressive neuromuscular functional decay in ALS and provide possible ‘response biomarkers’ in pre-clinical and clinical studies.
